Daily Baricitinib Treatment Preserves β-Cell Function in Type 1 Diabetes
Mixed-meal-stimulated mean C-peptide levels at 48 weeks higher for those treated with baricitinib versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.